13F HOLDINGS REPORT (Amended)
HBK INVESTMENTS L P
Quarter ended Q1 2023 · Filed February 14, 2023 · Accession 0001011443-23-000005
Total Value
$1.04B
Positions
9
Other Managers
0
Confidential Omitted
No
Holdings (9)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | CYRUSONE INC | 23283R100 | 3,150,000 | $282.6M | 27.07% |
| 2 | ATHENE HOLDING LTD | ATHS | 2,743,465 | $228.3M | 21.87% |
| 3 | CERNER CORP | 156782104 | 2,130,000 | $197.8M | 18.95% |
| 4 | VONAGE HLDGS CORP | 92886T201 | 6,046,844 | $125.7M | 12.04% |
| 5 | ARENA PHARMACEUTICALS INC | 040047607 | 761,800 | $70.8M | 6.78% |
| 6 | WELBILT INC | 949090104 | 2,400,000 | $57.0M | 5.46% |
| 7 | ROGERS CORP | ROG | 163,181 | $44.5M | 4.27% |
| 8 | VONAGE HLDGS CORP | 92886TAJ1 | 25,000,000 | $33.4M | 3.20% |
| 9 | ORTHO CLINICAL DIAGNOSTICS H | G6829J107 | 180,000 | $3.9M | 0.37% |